New cancer drug enters human testing: hopes for advanced tumor treatment
Disease control
Recruiting now
This is the first human study of an experimental drug called INI-4001 for people with advanced solid tumors that have spread. The main goal is to find a safe dose and see how the body handles the drug, both by itself and when combined with other approved cancer immunotherapies. R…
Phase: PHASE1 • Sponsor: Inimmune Corporation • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC